Boldenone Undecylenate 250 - Somatrop-Lab

Ciba development of Boldenone Undecylenate in the 1960 initially aimed at creating a human therapeutic drug, sold as Parenabol. However, it quickly shifted to the veterinary market, gaining significant traction under the brand Equipoise. After transitioning from Squibb to Solvay in 1985 and Wyeth in 1995, Equipoise is now under Pfizer portfolio. ​The chemical structure, which involves a modification of testosterone by the introduction of a double bond, gives it a more favorable anabolic-to-androgenic ratio. Its prolonged impact because of the ester has made it a popular choice for animal applications, like horses to enhance muscle mass and increase appetite stimulation.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Boldenone Undecylenate 250 by Somatrop-Lab, consult with your doctor or healthcare professional.